Table 1.
| ↑MPV in cardiovascular diseases | |
| Endler et al. 2002 [2] | Associated with a higher risk of acute cardiac incidents |
| Slavka et al. 2011 [3] | Independent high risk factor of death in patients after acute ischemic cardiac incident |
| Huczek et al. 2005 [4] | Related to the increased mortality rate in a six-month-period after the transdermal cardiac intervention |
| Shah et al. 2013 [5] | Associated with higher risk of death within a long time after the transdermal cardiac intervention |
| ↑MPV in cerebral stroke | |
| D'Erasmo et al. 1990 [6] | Increased MPV after stroke was related to higher mortality |
| Greisenegger et al. 2004 [7] | Associated with a risk of acute stroke |
| O'Malley et al. 1995 [8] | MPV as a prognostic marker in patients after stroke characteristic for acute and nonacute phases of cerebral ischemia |
| ↑MPV in respiratory diseases | |
| Feng et al. 2011 [9] Unsal et al. 2005 [10] |
In tuberculosis associated with intensity of inflammation |
| Koç et al. 2011 [11] | Associated with the development and course of the chronic sinusitis |
| ↑MPV in chronic renal failure | |
| Sharpe et al. 1994 [12] | In patients treated with recombinant erythropoietin (HuEPO) leading to higher risk of blood clot formation |
| ↑MPV in intestine diseases | |
| Liu et al. 2012 [13] | Differentiate patients with Crohn's disease from healthy subjects |
| Zubcevic et al. 2010 [14] | Marker of the Crohn's disease activity |
| ↑MPV in rheumatoid diseases | |
| Gasparyan et al. 2010 [15] | In rheumatoid arthritis, increased MPV is observed due to administration of anti-inflammatory drugs |
| Yavuz and Ece 2014 [16] | Correlated with the advancement of juvenile SLE |
| ↑MPV in diabetes | |
| Papanas et al. 2004 [17] | Associated with retinopathy and nephropathy |
| Rollini et al. 2013 [18] | Responsible for increased risk of diabetes and worse outcome |
| ↑MPV in carcinomas | |
| Kurt et al. 2012 [19] | Potential marker of liver cancer in patients with chronic liver diseases |
| Li et al. 2017 [20] | In colorectal cancer patients compared to healthy subjects |
| Tunce et al. 2014 [21] | In colorectal cancer patients with metastases compared to nonmetastatic colorectal cancer patients |
| Kılınçalp et al. 2014 [22] | In primary gastric cancer patients preoperative level considerably higher compared to healthy subjects |
| Matowicka-Karna et al. 2013 [23] | In preoperative gastric cancer associated with the disease progression |
| Gong et al. 2016 [24] | In preoperative pancreatic cancer patients compared to those having benign lesions of the organ and healthy subjects |
| Yin et al. 2018 [25] | Associated with worse survival outcome in patients with pancreatic cancer with synchronous liver metastases |
| Carlioglu et al. 2014 [26] | Observed in papillary thyroid cancer patients, correlated with tumor growth |